Pharmaceutical Production in Hungary is Specialised in the Production of Generic Drugs with Nearly 20 Original Molecules Developed During the Last Decade
Dublin (PRWEB) May 15, 2006
Research and Markets (http://www. researchandmarkets. com/reports/c36900 (http://www. researchandmarkets. com/reports/c36900)) has announced the addition of the Espicom Business Intelligence report “The Pharmaceutical Market: Hungary” to their offering
In May 2004, Hungary became a member of the European Union and is therefore allowed to trade freely within the EU, although restrictions have been imposed regarding pharmaceuticals.
Hungary represents one of the more advanced pharmaceutical markets of central Europe. The country has a strong tradition of pharmaceutical manufacturing and has always maintained a relatively high level of consumption; half of the adult population is on regular medication and 20% consumes more than five different drugs. Over the past few years, the government has introduced numerous policies regarding pharmaceutical pricing, in order to reduce the drugs budget deficit, but companies are still free to increase the prices of non-reimbursed drugs.
Pharmaceutical production in Hungary is specialised in the production of generic drugs. During the last decade, nearly 20 original molecules were developed. The main pharmaceutical companies were privatised in the period 1991-1996, starting with Chinoin. Gedeon Richter is controlled by foreign investors, whereas the majority share of equities in other companies are owned by foreign professional investors.
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. The report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
For more information visit http://www. researchandmarkets. com/reports/c36900 (http://www. researchandmarkets. com/reports/c36900)
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980
###
